(주)노브메타파마

{
  "address": "서울특별시 강남구",
  "ceo_name": "황선욱, 정회윤",
  "certificate": [
    {
      "cert_number": "20160113485",
      "changes": "",
      "disclosure_date": "2016-12-01",
      "first_cert_date": "2016-12-01",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2016-12-01 ~ 2018-11-30"
    },
    {
      "cert_number": "20180113424",
      "changes": "",
      "disclosure_date": "2018-11-26",
      "first_cert_date": "2016-12-01",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2018-12-01 ~ 2020-11-30"
    },
    {
      "cert_number": "20200114402",
      "changes": "",
      "disclosure_date": "2020-11-06",
      "first_cert_date": "2016-12-01",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2020-12-01 ~ 2022-11-30"
    },
    {
      "cert_number": "20221123020013",
      "changes": "",
      "disclosure_date": "2022-11-23",
      "first_cert_date": "2016-12-01",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2022-12-01 ~ 2025-11-30"
    },
    {
      "cert_number": "20251203020013",
      "changes": "",
      "disclosure_date": "2025-12-03",
      "first_cert_date": "2016-12-01",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2025-12-01 ~ 2028-11-30"
    }
  ],
  "company_name": "주식회사 노브메타파마",
  "financials": {
    "2022": {
      "capital_stock": 4862572000,
      "cost_of_sales": 15306000,
      "current_assets": 1105220000,
      "current_liabilities": 7117942000,
      "gross_profit": 16174000,
      "net_income": -6142414000,
      "net_income_bs": -6142414000,
      "non_current_assets": 2636752000,
      "non_current_liabilities": 861883000,
      "non_operating_expenses": 427117000,
      "non_operating_income": 1740318000,
      "operating_profit": -7455615000,
      "revenue": 31480000,
      "sga_expenses": 7471789000,
      "total_assets": 3741972000,
      "total_equity": -4237853000,
      "total_liabilities": 7979825000
    },
    "2023": {
      "capital_stock": 5545224000,
      "cost_of_sales": 6357000,
      "current_assets": 6418531000,
      "current_liabilities": 2917293000,
      "gross_profit": 7494000,
      "net_income": -12555184000,
      "net_income_bs": -12555184000,
      "non_current_assets": 2867305000,
      "non_current_liabilities": 796254000,
      "non_operating_expenses": 5074289000,
      "non_operating_income": 293356000,
      "operating_profit": -7774251000,
      "revenue": 13851000,
      "sga_expenses": 7781745000,
      "total_assets": 9285836000,
      "total_equity": 5572289000,
      "total_liabilities": 3713547000
    },
    "2024": {
      "capital_stock": 5655114000,
      "cost_of_sales": 14174000,
      "current_assets": 1652230000,
      "current_liabilities": 2672421000,
      "gross_profit": 31141000,
      "net_income": -5604651000,
      "net_income_bs": -5604651000,
      "non_current_assets": 2996297000,
      "non_current_liabilities": 219518000,
      "non_operating_expenses": 196912000,
      "non_operating_income": 132814000,
      "operating_profit": -5540553000,
      "revenue": 45315000,
      "sga_expenses": 5571694000,
      "total_assets": 4648527000,
      "total_equity": 1756588000,
      "total_liabilities": 2891939000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "phone": "02-538-****",
  "source": "pg_migration"
}